Atreca Interest Expense 2011-2026 | BCEL

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Atreca

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	3 K	4 K	6 K	9 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
9 K	3 K	5.5 K

Quarterly Interest Expense Atreca

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
434 K	564 K	521 K	-	233 K	153 K	794 K	-	1 K	1 K	1 K	-	1 K	1 K	1 K	-	1 K	2 K	2 K	-	3 K	2 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
794 K	1 K	160 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Adagene ADAG	1.11 M	$ 2.8	-3.69 %	$ 158 M	China
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
ANI Pharmaceuticals ANIP	-4.03 M	$ 80.89	-1.35 %	$ 1.56 B	USA
Aeglea BioTherapeutics AGLE	-20.7 M	-	-	$ 1.01 B	USA
Aytu BioScience AYTU	-512 K	$ 2.68	3.88 %	$ 16.8 M	USA
Alterity Therapeutics Limited ATHE	2.28 K	$ 3.23	-1.01 %	$ 7.77 B	Australia
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Aravive ARAV	2.84 M	-	-13.39 %	$ 1.45 M	USA
Brickell Biotech BBI	5 K	-	-5.38 %	$ 6.06 M	USA
Biogen BIIB	250 M	$ 177.21	0.61 %	$ 25.8 B	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Ascendis Pharma A/S ASND	65.5 M	$ 224.26	0.14 %	$ 5 B	Danmark
Athira Pharma ATHA	3.96 M	-	-	$ 269 M	USA
Arrowhead Pharmaceuticals ARWR	5.26 M	$ 68.78	-0.5 %	$ 9.2 B	USA
AgeX Therapeutics AGE	4.9 M	-	-10.17 %	$ 12.2 K	USA
CASI Pharmaceuticals CASI	2.9 K	$ 1.01	1.6 %	$ 137 M	USA
Catalyst Biosciences CBIO	1.04 M	$ 9.79	-3.55 %	$ 644 M	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Bellicum Pharmaceuticals BLCM	2.66 M	-	-9.72 %	$ 5.89 M	USA
Adaptimmune Therapeutics plc ADAP	-807 K	-	-15.15 %	$ 60.3 M	Britain
Berkeley Lights BLI	910 K	-	-7.31 %	$ 87 M	USA
Can-Fite BioPharma Ltd. CANF	227 K	$ 4.0	-3.61 %	$ 8.7 B	Israel
Amneal Pharmaceuticals AMRX	11.8 M	$ 14.0	-0.78 %	$ 4.33 B	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
Cerus Corporation CERS	1.98 M	$ 2.28	-1.94 %	$ 421 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
AlloVir ALVR	1.19 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Baudax Bio BXRX	1.36 M	-	0.59 %	$ 63 K	USA